[Attention deficit hyperactivity disorder]

Med Clin (Barc). 2015 Apr 20;144(8):370-5. doi: 10.1016/j.medcli.2014.02.025. Epub 2014 Apr 29.
[Article in Spanish]

Abstract

Attention deficit hyperactivity disorder (ADHD) is one of the most common childhood psychiatric disorders and can persist into the adulthood. ADHD has important social, academic and occupational consequences. ADHD diagnosis is based on the fulfillment of several clinical criteria, which can vary depending on the diagnostic system used. The clinical presentation can show great between-patient variability and it has been related to a dysfunction in the fronto-striatal and meso-limbic circuits. Recent investigations support a model in which multiple genetic and environmental factors interact to create a neurobiological susceptibility to develop the disorder. However, no clear causal association has yet been identified. Although multimodal treatment including both pharmacological and psychosocial interventions is usually recommended, no convincing evidence exists to support this recommendation. Pharmacological treatment has fundamentally shown to improve ADHD symptoms in the short term, while efficacy data for psychosocial interventions are scarce and inconsistent. Yet, drug treatment is increasingly popular and the last 2 decades have witnessed a sharp increase in the prescription of anti-ADHD medications coinciding with the marketing of new drugs to treat ADHD.

Keywords: Attention deficit hyperactivity disorder; Diagnosis; Diagnóstico; Neurobiology; Neurobiología; Pharmacological treatment; Psychosocial treatment; Review; Revisión; Trastorno por déficit de atención con hiperactividad; Tratamiento farmacológico; Tratamiento psicosocial.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Attention Deficit Disorder with Hyperactivity* / diagnosis
  • Attention Deficit Disorder with Hyperactivity* / etiology
  • Attention Deficit Disorder with Hyperactivity* / physiopathology
  • Attention Deficit Disorder with Hyperactivity* / therapy
  • Central Nervous System Agents / therapeutic use
  • Combined Modality Therapy
  • Humans
  • Neurofeedback
  • Psychotherapy

Substances

  • Central Nervous System Agents